JOHN K CLARKE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN K CLARKE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN K CLARKE. JOHN K CLARKE is a Director in CUBIST PHARMACEUTICALS INC ($CBST) and a Director in ALNYLAM PHARMACEUTICALS, INC. ($ALNY) and a Director in MOMENTA PHARMACEUTICALS INC ($MNTA) and a Director in aTYR PHARMA INC ($LIFE).
Address: CARDINAL HEALTH PARTNERS 221 NASSAU STREET PRINCETON 08542 NJ
Companies in which JOHN K CLARKE is an Insider
ALNYLAM PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN K CLARKE: Director
Holdings: 23,891 shares
Current Value: $966,630
Latest Transaction: Jun 22 2018
$ALNY Market Capitalization: $3.49B
$ALNY Previous Close: $40.46
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
aTYR PHARMA INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHN K CLARKE: Director
Holdings: 117,843 shares
Current Value: $400,666
Latest Transaction: Apr 29 2021
$LIFE Market Capitalization: $78.27M
$LIFE Previous Close: $3.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CUBIST PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN K CLARKE: Director
Holdings: 1,700 shares
Latest Transaction: Jan 27 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MOMENTA PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHN K CLARKE: Director
Holdings: 69,123 shares
Current Value: $1,302,969
Latest Transaction: Jun 11 2015
$MNTA Market Capitalization: $1.29B
$MNTA Previous Close: $18.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of JOHN K CLARKE
Sentiment: All, ALNY, LIFE, CBST, MNTA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 2021 | LIFE | aTYR PHARMA INC | CLARKE JOHN K | Director | Option Exercise | A | 4.21 | 1,428 | 6,012 | 1,428 | |
| Sep 03 2020 | LIFE | aTYR PHARMA INC | CLARKE JOHN K | Director | Sell | S | 4.01 | 7,260 | 29,113 | 110,583 | 117.8 K to 110.6 K (-6.16 %) |
| Sep 03 2020 | LIFE | aTYR PHARMA INC | CLARKE JOHN K | Director | Sell | S | 4.00 | 100 | 400 | 117,843 | 117.9 K to 117.8 K (-0.08 %) |
| Aug 28 2020 | LIFE | aTYR PHARMA INC | CLARKE JOHN K | Director | Sell | S | 4.09 | 5,440 | 22,250 | 117,943 | 123.4 K to 117.9 K (-4.41 %) |
| Aug 28 2020 | LIFE | aTYR PHARMA INC | CLARKE JOHN K | Director | Sell | S | 4.30 | 2,200 | 9,451 | 123,383 | 125.6 K to 123.4 K (-1.75 %) |
| Aug 28 2020 | LIFE | aTYR PHARMA INC | CLARKE JOHN K | Director | Sell | S | 4.09 | 5,440 | 22,250 | 117,943 | 123.4 K to 117.9 K (-4.41 %) |
| Aug 28 2020 | LIFE | aTYR PHARMA INC | CLARKE JOHN K | Director | Sell | S | 4.30 | 2,200 | 9,451 | 123,383 | 125.6 K to 123.4 K (-1.75 %) |